Detalhe da pesquisa
1.
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol
; 23(10): 1495-1506, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151395
2.
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Nature
; 622(7984): 850-862, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794185
3.
Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study.
Neuroendocrinology
; 110(1-2): 50-62, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31030198
4.
CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma.
Cancer Immunol Immunother
; 67(9): 1449-1459, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030558
5.
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
Nat Commun
; 12(1): 6423, 2021 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741035
6.
Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.
JCI Insight
; 52019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31219806
7.
Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
PLoS One
; 13(3): e0194888, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29566080
8.
Neoepitopes as cancer immunotherapy targets: key challenges and opportunities.
Immunotherapy
; 9(4): 361-371, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303769
9.
Tumor Control Index as a new tool to assess tumor growth in experimental animals.
J Immunol Methods
; 445: 71-76, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28336396